Therefore, high dietary selenium intake may increase NAFLD risk by dysregulating insulin biosynthesis and secretion and stimulating glucagon secretion, insulin resistance, and dyslipidemia [38]. This evidence concerns the gene GCG and metabolic dysfunction-associated steatotic liver disease.